NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SOM Biotech

SOM Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://sombiotech.com/

Last Round

VC Round

Mar 12, 2024

Total Funding Raised

$28.39M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SOM Biotech is a biopharmaceutical company that discovers and develops drugs for the treatment of rare and critical diseases using a proprietary AI-based drug discovery technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug repurposingAI drug discoveryin-silico drug discoverycomputational drug discoveryrare diseasesorphan diseasesneurological disordersdrug discovery platformdrug out-licensingcentral nervous system disordersCNS disordersclinical stage biotechbiotech partnershipsmolecular field matchingHuntington's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SOM Biotech Comparables

Compare SOM Biotech with similar companies based on industry and business-model similarity.

SOM Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Delta4
84%
Healx
82%
VeriSIM Life
78%

SOM Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 12, 2024
Series BNov 1, 2023
Series AMar 7, 2019
SeedJan 20, 2017

Key People

Founding team and executive leadership

Silvia Panigone

Chief Executive Officer

Executive Team

Oscar Huertas

Chief Technology Officer

Executive Team

SOM Biotech Investors

Notable investors and investment history

SOM Biotech investors
InvestorRounds
European Investment Bank GroupSeries B
Prevail PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 56% MoM.

  • Mar 12, 2024

    $6M raised in a VC Round.

SOM Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SOM Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SOM Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range15
Year Founded2009
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.